Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Sports Medicine
Published in: Sports Medicine 11/2016

01-11-2016 | Review Article

The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions

Authors: J. Chris Baldi, Genevieve A. Wilson, Luke C. Wilson, Gerard T. Wilkins, Regis R. Lamberts

Published in: Sports Medicine | Issue 11/2016

Login to get access

Abstract

The metabolic and microvascular benefits of regular exercise for people with diabetes are unequivocal. However, cardiovascular disease, which disproportionately affects people with diabetes, is not reduced by regular exercise, and heart disease remains the leading cause of death for people with type 2 diabetes. ‘Subclinical’ changes in the function of the diabetic left ventricle are common and reduce cardiac reserve and exercise capacity. This review describes the changes in resting and exercising left ventricular function, and the possible causes of these changes, and introduces the possibility that more vigorous exercise may be needed to improve left ventricular function and reduce rates of cardiovascular disease in people with type 2 diabetes.
Literature
1.
Green S, Egańa M, Baldi JC, Lamberts R, Regensteiner JG. Cardiovascular control during exercise in type 2 diabetes mellitus. J Diabetes Res. 2015;2015:654204.PubMedPubMedCentralCrossRef
2.
Baldi JC, Aoina JL, Oxenham HC, Bagg W, Doughty RN. Reduced exercise arteriovenous O2 difference in type 2 diabetes. J Appl Physiol. 2003;94:1033–8.PubMedCrossRef
3.
Gusso S, Hofman P, Lalande S, Cutfield W, Robinson E, Baldi JC. Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus. Diabetologia. 2008;51:1317–20.PubMedCrossRef
4.
MacAnaney O, Malone J, Warmington S, O’Shea D, Green S, Egana M. Cardiac output responses are not related to the slowed oxygen uptake kinetics in type 2 diabetes. Med Sci Sports Exerc. 2011;43:935–42.CrossRef
5.
Lee MJ, Coast JR, Hempleman SC, Baldi JC. Type 1 diabetes duration decreases pulmonary diffusing capacity during exercise. Respiration. 2016;91(2):164–70.PubMedCrossRef
6.
Niranjan V, McBrayer DG, Ramirez LC, Rasking P, Hsia CCW. Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med. 1997;103:504–13.PubMedCrossRef
7.
O’Connor E, Green S, Kiely C, O’Shea D, Egana M. Differential effects of age and type 2 diabetes on dynamic versus peak response of pulmonary oxygen uptake during exercise. J Appl Phys. 2015;118:1031–9.
8.
Baldi JC, Cassuto NA, Foxx-Lupo WT, Wheatley CM, Snyder EM. Glycemic status affects cardiopulmonary exercise response in athletes with type 1 diabetes. Med Sci Sports Exerc. 2010;42:1454–9.PubMedCrossRef
9.
Pinto TE, Gusso S, Hofman PL, Derraik JG, Hornung TS, Cutfield WS, Baldi JC. Systolic and diastolic abnormalities reduce the cardiac response to exercise in adolescents with type 2 diabetes. Diabetes Care. 2014;37:1439–46.PubMedCrossRef
10.
Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest. 1977;60:884–99.PubMedCrossRef
11.
Keytsman C, Dendale P, Hansen D. Chronotropic incompetence during exercise in type 2 diabetes: aetiology, assessment methodology, prognostic impact and therapy. Sports Med. 2015;45:985–95.PubMedCrossRef
12.
Gerson MC, Khoury JC, Hertzberg VS, et al. Prediction of coronary artery disease in a population of insulin-requiring diabetic patients: results of an 8-year follow up study. Am Heart J. 1988;116:820–6.PubMedCrossRef
13.
Felsher J, Meissner MD, Hakki AH. Exercise thallium imaging in patients with diabetes mellitus: prognostic implications. Arch Intern Med. 1987;147:313–7.PubMedCrossRef
14.
Roy TM, Peterson HR, Snider HL, Cyrus J, Broadstone VL, Fell RD, Rothchild AH, Samois E, Pfeifer MA. Autonomic influence on cardiovascular performance in diabetic subjects. Am J Med. 1989;87:382–8.PubMedCrossRef
15.
van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJJ, Schalkwijk CG, Bronzwaer JGF, Diamant M, Borbely A, van der Velden J, Stienen GJM, Laarman GJ, Miessen HWM, Paulus WJ. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117:43–51.PubMedCrossRef
16.
van Hoeven KH, Factor SM. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive–diabetic heart disease. Circulation. 1990;82:848–55.PubMedCrossRef
17.
Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315–21.PubMedCrossRef
18.
Asif M, Egan J, Vasan S, Jyothirmayi GN, Masurekar MR, Lopez S, Williams C, Torres RL, Wagle D, Ulrich P, Cerami A, Brines M, Regan TJ. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci. 2000;97:2809–13.PubMedPubMedCentralCrossRef
19.
Campbell DJ, Somaratne JB, Jenkins AJ, Prior DL, Yii M, Kenny JF, Newcomb AE, Schalkwijk CG, Black MJ, Kelly DJ. Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease. Cardiovasc Diabetol. 2011;10:80.PubMedPubMedCentralCrossRef
20.
Hamdani N, Franssen C, Lourenço A, Falcão-Pires I, Fontoura D, Leite S, Plettig L, López B, Ottenheijm CA, Becher PM, González A, Tschöpe C, Diez J, Linke WA, Leite-Moreira AF, Paulus WJ. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model. Circ Heart Fail. 2013;6:1239–49.PubMedCrossRef
21.
Lalande S, Hofman PL, Baldi JC. Effect of reduced total blood volume on left ventricular volumes and kinetics in type 2 diabetes. Acta Physiol. 2010;199:23–30.CrossRef
22.
Regensteiner JG, Bauer TA, Reusch JEB, Quaife RA, Chen MY, Smith SC, Miller TM, Groves BM, Wolfel EE. Cardiac dysfunction during exercise in uncomplicated type 2 diabetes. Med Sci Sport Exerc. 2009;41:977–84.CrossRef
23.
Regan TJ, Ettinger PO, Khan MI, Jesrani MU, Lyons MM, Oldewurtel HA, Weber M. Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res. 1974;35:222–37.CrossRef
24.
Baldi JC, Aoina JL, Whalley GA, Carrick-Ranson G, Walsh HA, O’Shaughnessy H, Bagg W, Doughty RN. The effect of type 2 diabetes on diastolic function. Med Sci Sports Exerc. 2006;38:1384–8.PubMedCrossRef
25.
Belke DD, Swanson EA, Dillmann WH. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes. 2004;53:3201–8.PubMedCrossRef
26.
Lamberts RR, Lingam SJ, Wang HY, Bollen IA, Hughes G, Galvin IF, Bunton RW, Bahn A, Katare R, Baldi JC, Williams MJ, Saxena P, Coffey S, Jones PP. Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction. Cardiovasc Diabetol. 2014;13:72.PubMedPubMedCentralCrossRef
27.
Whalley GA, Gusso S, Hofman P, Cutfield W, Poppe KK, Doughty RN, Baldi JC. Structural and functional cardiac abnormalities in adolescent girls with poorly controlled type 2 diabetes. Diabetes Care. 2009;32:883–8.PubMedPubMedCentralCrossRef
28.
Gledhill N, Cox D, Jamnik R. Endurance athletes’ stroke volume does not plateau: major advantage is diastolic function. Med Sci Sports Exerc. 1994;26:1116–21.PubMedCrossRef
29.
Stolen TO, Høydal MA, Kemi OJ, Catalucci D, Ceci M, Aasum E, Larsen T, Rolim N, Condorelli G, Smith GL, Wisløff U. Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res. 2009;105:527–36.PubMedCrossRef
30.
Bussey CT, Hughes G, Saxena P, Galvin IF, Bunton RW, Noye MK, Coffey S, Williams MJ, Baldi JC, Jones PP, Lamberts RR. Chamber-specific changes in calcium-handling proteins in the type 2 diabetic human heart with preserved ejection fraction. Int J Cardiol. 2015;193:53–5.PubMedCrossRef
31.
Reuter H, Grönke S, Adam C, Ribati M, Brabender J, Zobel C, Frank KF, Wippermann J, Schwinger RH, Brixius K, Müller-Ehmsen J. Sarcoplasmic Ca+ release is prolonged in nonfailing myocardium of diabetic patients. Mol Cell Biochem. 2008;308:141–9.PubMedCrossRef
32.
Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24:5–10.PubMedCrossRef
33.
Sohn DW, Chai H, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997;30:474–80.PubMedCrossRef
34.
Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30:1527–33.PubMedCrossRef
35.
Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler–catheterization study. Circulation. 2000;102:1788–94.PubMedCrossRef
36.
Firstenberg MS, Levine BD, Garcia MJ, Greenberg NL, Cardon L, Morehead AJ, Zuckerman J, Thomas JD. Relationship of echocardiographic indices to pulmonary capillary wedge pressures in healthy volunteers. J Am Coll Cardiol. 2000;36:1664–9.PubMedCrossRef
37.
Sasso FC, Carbonara O, Cozzolino D, Rambaldi P, Mansi L, Torella D, Gentile S, Turco S, Torella R, Salvatore T. Effects of insulin–glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients. J Am Coll Cardiol. 2000;36:219–26.PubMedCrossRef
38.
Carrick-Ranson G, Doughty RN, Whalley GA, Walsh HJ, Gamble GD, Baldi JC. The larger exercise stroke volume in endurance-trained men does not result from increased left ventricular early or late inflow or tissue velocities. Acta Physiol. 2012;205:521–31.CrossRef
39.
Thackery JT, Beanlands RS, DaSilva JN. Altered sympathetic nervous sytem signalling in the diabetic heart: emerging targets for molecular imaging. Am J Nucl Med Mol Imaging. 2012;2:314–34.
40.
Alvarez JA, Reyes M, Escobedo D, Freeman GL, Steinhelper ME, Feldman MD. Enhanced left ventricular systolic function early in type 2 diabetic mice: clinical implications. Diab Vasc Dis Res. 2004;1:89–94.PubMedCrossRef
41.
Fredersdorf S, Thumann C, Ulucan C, Griese DP, Luchner A, Riegger GA, Kromer EP, Weil J. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol. 2004;13:11–9.PubMedCrossRef
42.
Rösen P, Herberg L, Reinauer H, Adriean M, Feuerstein J, Topütt B. Different types of post insulin receptor defects contribute to insulin resistance in hearts of obese Zucker rats. Endocrinology. 1986;119:1285–91.PubMedCrossRef
43.
Celentano A, Vaccaro O, Tammaro P, Galderisi M, Crivaro M, Oliviero M, Imperatore G, Palmieri V, Iovino V, Riccardi G, Devitiis O. Early abnormalities of cardiac function in non-insulin dependent diabetes mellitus and impaired glucose tolerance. Am J Cardiol. 1995;76:1173–6.PubMedCrossRef
44.
Mustonen JN, Uusitupa MIJ, Tahvanainen K, Talwar S, Laakso M, Länsimies E, Kuikka JT, Pyörälä K. Impaired left ventricular systolic function during exercise in middle-aged insulin-dependent and noninsulin-dependent diabetic subjects without clinically evident cardiovascular disease. Am J Cardiol. 1988;62:1273–9.PubMedCrossRef
45.
Ferraro S, Perrone-Filardi P, Maddalena G, Desiderio A, Gravina E, Turco S, Chiariello M. Comparison of left ventricular function in insulin- and non-insulin dependent diabetes mellitus. Am J Cardiol. 1993;71:409–14.PubMedCrossRef
46.
Ehl NF, Kühne M, Brinkert M, Müller-Brand J, Zellweger MJ. Diabetes reduces left ventricular ejection fraction—irrespective of presence and extent of coronary artery disease. Eur J Endocrinol. 2011;165:945–51.PubMedCrossRef
47.
Ha JW, Lee HC, Kang ES, Aghn CM, Kim JM, Ahn JA, Lee SW, Choi EY, Rim SJ, Oh JK, Chung N. Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. Heart. 2007;93:1571–6.PubMedPubMedCentralCrossRef
48.
Zhen Z, Chen Y, Shih K, Liu JH, Yuen M, Wong DS, Lam KS, Tse HF, Yiu KH. Altered myocardial response in patients with diabetic retinopathy: an exercise echocardiography study. Cardiovasc Diabetol. 2015;14:123.PubMedPubMedCentralCrossRef
49.
Aboukhoudir F, Rekik S. Left ventricular systolic function deterioration during dobutamine stress echocardiography as an early manifestation of diabetic cardiomyopathy and reversal by optimized therapeutic approach. Int J Cardiovasc Imaging. 2012;6:1329–39.CrossRef
50.
Vinereanu D, Nicolaides E, Tweddel AC, Mädler CF, Holst B, Boden LE, Cinteza M, Rees AE, Fraser AG. Subclinical left ventricular dysfunction in asymptomatic patients with type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond). 2003;105:591–9.CrossRef
51.
Galderisi M, de Simone G, Innelli P, Turco A, Turco S, Capaldo B, Riccardi G, de Divitiis O. Impaired inotropic response in type 2 diabetes mellitus: a strain rate imaging study. Am J Hypertens. 2007;20:548–55.PubMedCrossRef
52.
53.
Robinson BF, Epstein SE, Beiser GD, Braunwald E. Control of heart rate by the autonomic nervous system: studies in man on the inter-relation between baroreceptor mechanisms and exercise. Circ Res. 1966;19:400–11.PubMedCrossRef
54.
55.
Bottini P, Tantucci C, Scionti L, et al. Cardiovascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity. Diabetologia. 1995;38:244–50.PubMedCrossRef
56.
Hilsted J. Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal, and metablic studies. Diabetes. 1982;31:730–7.PubMedCrossRef
57.
58.
Scott JA, Coombes JS, Prins JB, Leano RL, Marwick TH, Sharman JE. Patients with type 2 diabetes have exaggerated brachial and central exercise blood pressure: relation to left ventricular relative wall thickness. Am J Hypertension. 2008;21:715–21.CrossRef
59.
Liao D, Cai J, Brancati FL, Folsom A, Barnes RW, Tyroler HA, Heiss G. Association of vagal tone with serum insulin, glucose, and diabetes mellitus—the ARIC study. Diabetes Res Clin Pract. 1995;30:211–21.PubMedCrossRef
60.
Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1981;30:219–25.PubMedCrossRef
61.
Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, Heiss G. Diabetes, glucose, insulin, and heart rate variability. Diabetes Care. 2005;28:668–74.PubMedCrossRef
62.
Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atheroslcerosis Risk In Communities study, 1987, 1998. Circulation. 2003;107:2190–5.PubMedCrossRef
63.
Facchini FS, Stoohs RA, Reaven GM. Enhanced sympathetic nervous system activity: the linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens. 1996;9:1013–7.PubMedCrossRef
64.
Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism. 2008;57:1422–7.PubMedCrossRef
65.
Landsberg L, Saville ME, Young JB. Sympathoadrenal system and regulation of thermogenesis. Am J Physiol. 1986;247:E181–9.
66.
Thaung HP, Baldi JC, Wang HY, Hughes G, Cook RF, Bussey CT, Sheard PW, Bahn A, Jones PP, Schwenke DO, Lamberts RR. Increased efferent cardiac sympathetic nerve activity and defective intrinsic heart rate regulation in type 2 diabetes. Diabetes. 2015;64:2944–56.PubMedCrossRef
67.
Christensen TE, Kjaer A, Hasbak P. The clinical value of cardiac sympathetic imaging in heart failure. Clin Physiol Funct Imaging. 2014;334:178–82.CrossRef
68.
Yufu K, Takahashi N, Okada N, Shinohara T, Nakagawa M, Hara M, Yoshimatsu H, Saikawa T. Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease. Circ J. 2012;76:399–404.PubMedCrossRef
69.
Nagamachi S, Fujita S, Nishii R, Futami S, Tamura S, Mizuta M, et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol. 2006;13:34–42.PubMedCrossRef
70.
Scognamiglio R, Avogaro A, Casara D, Crepaldi C, Marin M, Palisi M, Mingardi R, Erle G, Fasoli G, Volta SD. Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1998;31:404–12.PubMedCrossRef
71.
Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol. 1993;22:61A–71A.PubMedCrossRef
72.
Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shas P, Jamieson S, Stinson EB. β1- and β2-adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1-receptor down-regulation in heart failure. Circ Res. 1986;59:297–309.PubMedCrossRef
73.
Gautier C, Tavernier G, Charpentier F, Le Langin D, Marec H. Functional beta3-adrenoceptor in the human heart. J Clin Invest. 1996;98:556–62.CrossRef
74.
75.
Dincer UD, Bidasee KR, Guner S, Tay A, Ozcelikay AT, Altan VM. The effect of diabetes on expression of beta1-, beta2, and beta3-adrenoreceptors in rat hearts. Diabetes. 2001;50:455–61.PubMedCrossRef
76.
Savarese JJ, Berkowitz BA. Β-adrenergic receptor decrease in diabetic rat hearts. Life Sci. 1979;25:2075–8.PubMedCrossRef
77.
Sellers DJ, Chess-Williams R. The effect of streptozotocin-induced diabetes on cardiac beta-adrenoceptor subtypes in the rat. J Auton Pharmacol. 2001;21:15–21.PubMedCrossRef
78.
Dincer UD, Guner S, Tay A, Arioglu E, Tasdelen A, Aslamaci S, Bidasee KR. Decreased expression of beta1- and beta2-adrenoceptors in human diabetic atrial appendage. Cardiovasc Diabetol. 2003;2:6.PubMedPubMedCentralCrossRef
79.
Haley JM, Thackeray JT, Thorn SL, DaSilva JN. Cardiac β-adrenoceptor expression is reduced in Zucker diabetic fatty rats as type 2 diabetes progresses. PLoS One. 2015;10:e0127581.PubMedPubMedCentralCrossRef
80.
Dutta K, Podolin DA, Davidson MB, Davidoff AJ. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes. 2001;50:1186–92.PubMedCrossRef
81.
Radovits T, Korkmaz S, Loganathan S, Barnucz E, Bömicke T, Arif R, Karck M, Szabó G. Comparative investigation of the left ventricular pressure–volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2009;297:H125–33.PubMedCrossRef
82.
Pereira L, Matthes J, Schuster I, Valdivia HH, Herzig S, Richard S, Gómez AM. Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes. 2006;55:608–15.PubMedCrossRef
83.
Bidasee KR, Nallani K, Henry B, Dincer UD, Besch HR Jr. Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts. Mol Cell Biochem. 2003;249:113–23.PubMedCrossRef
84.
Jweied EE, McKinney RD, Walker LA, Brodsky I, Geha AS, Massad MG, Buttrick PM, de Tombe PP. Depressed cardiac myofilament function in human diabetes mellitus. Am J Physiol Heart Circ Physiol. 2005;289:H2478–83.PubMedCrossRef
85.
Landzberg JS, Parker JD, Gauthier DF, Colucci WS. Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation. 1994;89:164–8.PubMedCrossRef
86.
Ewing DJ, Campbell IW, Clarke BF. Heart rate changes in diabetes mellitus. Lancet. 1981;317:183–6.CrossRef
87.
Ewing DJ, Irving JB, Kerr F, Wildsmith JAW, Clarke BF. Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function. Clin Sci Mol Med. 1974;46:295–306.PubMed
88.
89.
Koh J, Brown TE, Beightol LA, Ha CY, Eckberg DL. Human autonomic rhythms: vagal cardiac mechanisms in tetraplegic subjects. J Physiol (Lond). 1994;474:483–95.PubMedCentralCrossRef
90.
Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985;248:H151–3.PubMed
91.
Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol. 2008;51:1725–33.PubMedCrossRef
92.
Fang ZY, Prins JB, Sharman J, Marwick TH. Determinants of exercise capacity in patients with type 2 diabetes. Diabetes Care. 2005;28:1643–8.PubMedCrossRef
93.
UKPDS Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
94.
UKPDS Study Group. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care. 2002;25(Suppl 1):S28–32.
95.
Holman RR, Paul SK, Bethel MS, Matthews DR, Neil AW. 10-year follow-up of intensive glycose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.PubMedCrossRef
96.
University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes. 1970;19(Suppl 2):747–830.
97.
Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kohima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103–17.PubMedCrossRef
98.
Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med. 1997;157:181–8.PubMedCrossRef
99.
The ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818–28.PubMedCentralCrossRef
100.
The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.PubMedCentralCrossRef
101.
Saltin B, Blomqvist G, Mitchell JH, Johnson RL Jr, Wildenthal K, Chapman CB. Response to exercise after bed rest and after training. Circulation. 1968;38(5 Suppl):VII1–78.PubMed
102.
Myers J, Prakash M, Froelicher V, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793–801.PubMedCrossRef
103.
Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA. 2002;288:1994–2000.PubMedCrossRef
104.
Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol. 1974;34:29–34.PubMedCrossRef
105.
Boule’ NG, Kenny GP, Haddad E, Wells GA, Sigal RJ. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in type 2 diabetes mellitus. Diabetologia. 2003;46:1071–81.CrossRef
106.
Trovati M, Carta Q, Franco Cavalot SV, Banaudi C, Lucchina PG, Fiocchi F, Emanuelli G, Lenti G. Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care. 1984;7:416–20.PubMedCrossRef
107.
Saltin B, Lindgarde F, Houston M, Horlin R, Nygaard E, Gad P. Physical training and glucose tolerance in middle-aged men with chemical diabetes. Diabetes. 1979;28(Suppl 1):30–2.PubMedCrossRef
108.
Brandenburg SL, Reusch JEB, Bauer TA, Jeffers BW, Hiatt WR, Regensteiner JG. Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care. 1999;22:1620–46.CrossRef
109.
The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.PubMedCentralCrossRef
110.
Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, Jackson N, Fitzsimons K, Bright J, Coulman K, England CY, Gorton J, McLenaghan A, Paxton E, Polet A, Thompson C, Dayan CM. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID Randomised Controlled Trial. Lancet. 2011;378:129–39.PubMedCrossRef
111.
Bogardus C, Ravussin E, Robbins DC, Wolfe RR, Horton ES, Sims EAH. Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes. 1984;33:311–8.PubMedCrossRef
112.
Wycherley TP, Brinkworth GD, Noakes M, Buckley JD, Clifton PM. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes. Diabetes Obes Metab. 2008;10:1062–73.PubMedCrossRef
113.
Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33:e147–67.PubMedPubMedCentralCrossRef
114.
Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273:402–7.PubMedCrossRef
115.
Haskell WL, Lee I-M, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1081–93.PubMedCrossRef
116.
Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med. 1994;330:1549–54.PubMedCrossRef
117.
Lee I-M, Sesso HD, Oguma Y, Paffenbarger RS Jr. Relative intensity of physical activity and risk of coronary heart disease. Circulation. 2003;107:1110–6.PubMedCrossRef
118.
Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141–7.PubMedCrossRef
119.
Sesso HD, Stampfer MJ, Rosner B, Baziano JM, Hennekens CH. Two-year changes in blood pressure and subsequent risk of cardiovascular disease in men. Circulation. 2000;102:975–80.PubMedCrossRef
120.
Swain DP, Franklin BA. Comparison of cardioprotective benefits of vigorous versus moderate intensity aerobic exercise. Am J Cardiol. 2006;97:141–7.PubMedCrossRef
121.
Bergman H, Varnauskas E. The hemodynamic effects of physical training in coronary patients. Med Sport. 1970;4:138.
122.
Clausen JP, Larsen OA, Trap-Jensen J. Physical training in the management of coronary artery disease. Circulation. 1969;40:143–54.PubMedCrossRef
123.
Clausen JP, Trap-Jensen J. Effects of training on the distribution of cardiac output in patients with coronary artery disease. Circulation. 1970;42:611–24.PubMedCrossRef
124.
Detry JM, Rousseau M, Vandenbroucke G, Kusumi F, Brasseur LA, Bruce RA. Increased arteriovenous oxygen differences after physical training in coronary heart disease. Circulation. 1971;44:109–18.PubMedCrossRef
125.
Hagberg JM, Ehsani AA, Holloszy JO. Effect of 12 months of exercise training on stroke volume in patients with coronary artery disease. Circulation. 1983;67:1194–9.PubMedCrossRef
126.
Ekblom B, Åstrand P-O, Saltin B, Stenberg J, Wallström B. Effect of training on circulatory response to exercise. J Appl Physiol. 1968;24:518–28.PubMed
127.
Seals DR, Hagberg JM, Hurley BF, Ehsani AA, Holloszy JO. Endurance training in older men and women: cardiovascular responses to exercise. J Appl Physiol. 1984;57:1024–9.PubMed
128.
Wisløff U, Støylen A, Loennechen JP, Bruvold M, Rognmo Ø, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen Ø, Skjærpe T. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007;115:3086–94.PubMedCrossRef
129.
Cassidy S, Thoma C, Hallsworth K, Parikh J, Hollingsworth KG, Taylor R, Jakovlejevic DG, Trenell MI. High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2016;59(1):56–66.PubMedCrossRef
130.
Rognmo Ø, Moholdt T, Bakken H, Hole T, Mølstad P, Myhr NE, Grimsmo J, Wisløff U. Cardiovascular risk of high-versus moderate-intensity aerobic exercise in coronary heart disease patients. Circulation. 2012;126:1436–40.PubMedCrossRef
131.
Iscoe KE, Riddell MC. Continuous moderate-intensity exercise with or without intermittent high-intensity work: effects on acute and late glycaemia in athletes with type 1 diabetes mellitus. Diabet Med. 2011;28:824–32.PubMedCrossRef
132.
American College of Sports Medicine. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. Med Sci Sport Exerc. 1990;22:265–74.
133.
Martinez N, Kilpatrick MW, Salomon K, Jung ME, Little JP. Affective and enjoyment responses to high-intensity interval training in overweight-to-obese and insufficiently active adults. J Sport Exerc Psychol. 2015;37:138–49.PubMedCrossRef
134.
Jung ME, Bourne JE, Beauchamp MR, Robinson E, Little JP. High-intensity interval training as an efficacious alternative to moderate-intensity continuous training for adults with prediabetes. J Diabetes Res. 2015;2015:191595.PubMedPubMedCentralCrossRef
Metadata
Title
The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions
Authors
J. Chris Baldi
Genevieve A. Wilson
Luke C. Wilson
Gerard T. Wilkins
Regis R. Lamberts
Publication date
01-11-2016
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 11/2016
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.1007/s40279-016-0542-9

Other articles of this Issue 11/2016

Sports Medicine 11/2016 Go to the issue

Letter to the Editor

Author’s Reply to Sani et al.: “Effects of Exercise Training in Hypoxia Versus Normoxia on Vascular Health: Comments on Clinical Importance”—Facing Common Misconceptions Concerning Meta-Analysis in Biomedical Research

Letter to the Editor

Effects of Exercise Training in Hypoxia Versus Normoxia on Vascular Health: Comments on Clinical Importance

Systematic Review

Effects of Exercise Training in Hypoxia Versus Normoxia on Vascular Health

Systematic Review

Correlates of Gross Motor Competence in Children and Adolescents: A Systematic Review and Meta-Analysis

Systematic Review

Efficacy of Exercise Intervention for Weight Loss in Overweight and Obese Adolescents: Meta-Analysis and Implications

Review Article

Minimizing Head Acceleration in Soccer: A Review of the Literature